ACADIA Pharmaceuticals (ACAD)
(Delayed Data from NSDQ)
$16.82 USD
-0.25 (-1.46%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $16.82 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $0.18 | -47.87% |
Earnings Summary
For their last quarter, ACADIA Pharmaceuticals (ACAD) reported earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.32 per share. This reflects a negative earnings surprise of 12.50%. Look out for ACAD's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of $0.18 per share, reflecting a year-over-year increase of 166.67%.
Earnings History
Price & Consensus
Zacks News for ACAD
Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
ACAD: What are Zacks experts saying now?
Zacks Private Portfolio Services